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Background/objective: Contact dermatitis to topical medicaments is commonly encountered in daily
practice of dermatologists. The incidence and ranking of common allergens in topical medicaments may
vary depending on local prescription and self-medication behavior. The objective of this study is to
investigate the clinical features and common allergens of contact dermatitis to topical medicaments in
Taiwan.
Methods: From 1978 to 2005, a total of 3717 patients had been patch tested in our Contact Dermatitis
Clinic. Any case with suspected contact allergy to topical medicaments receiving patch testing was
included in this study.
Results: During this period, a total of 608 patients were included and 603 of them completed the patch
tests. Of the 603 patch-tested patients, 397 (66%) were positive for at least one antigen, and all patch
tests were negative in 206 (34%). Patients with positive patch testing were characterized by younger age
and location on the limbs and skin folds, while sex and atopy were not different among the two groups. A
total of 1076 positive reactions to identiﬁable medicaments or main ingredients were recorded in 397
patients with positive patch testing. Among these positive reactions, 701/1076 counts (65%) were read as
relevant. Traditional herbal medicaments (50%), antiseptics (21%), vehicle ingredients (9%), antibiotics
(8%), corticosteroids (2%), anesthetics (2%), and nonsteroidal anti-inﬂammatory drugs (1%) were the most
common sensitizers in this study, and the common concomitant allergens were fragrance (52%) and
metal (20%).
Conclusion: The results emphasized the special cultural consideration in Taiwanese patients with contact
dermatitis to topical medicaments.
Copyright © 2015, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Allergic contact dermatitis (ACD) is an inﬂammatory disease caused
by type IV delayed hypersensitivity.1 In daily clinical practice, der-
matologists prescribe various topical medicaments. The use ofy have no ﬁnancial or non-
atter or materials discussed
y, National Taiwan University
n.
cal Association. Published by Elsevover-the-counter topical agents is also very popular. Thus, sensiti-
zation to topical medicaments occurs from time to time.
Previous studies showed that the prevalence of ACD to topical
medicaments varied from 14% to 40% of patients in contact
clinics.2,3 Common allergens in medicaments include local anes-
thetics, antibiotics, antimicrobials, antivirals, antimycotics, corti-
costeroids, antihistamines, nonsteroidal anti-inﬂammatory drugs
(NSAIDs), and ingredients of the vehicles.1e3 However, the inci-
dence and ranking of culprit allergens in topical medicaments may
differ across the world due to different local prescribing and self-
medication habits.4
Factors predisposing to medicament contact dermatitis include
the intrinsic sensitizing potential of each drug, higher concentra-
tions, increased penetration, older age,5 damaged skin barrier, andier Taiwan LLC. All rights reserved.
Table 1 Demographic characteristics of patient population.
Medicament (þ) Medicament () p
Age (y)a 36.9 ± 15.9 40.1 ± 17.5 0.024*
Sexb Male: 133 (33.5) Male: 63 (30.6) 0.468
Female: 264 (66.5) Female: 143 (69.4)
Lesion site Faceb: 124 (31.2) Face: 94 (45.6) <0.001**
Trunkc: 3 (0.8) Trunk: 9 (4.4) 0.004***
Upper limbsb: 113 (28.5) Upper limbs: 39 (18.9) 0.011**
Lower limbsb: 161 (40.6) Lower limbs: 59 (28.6) 0.004**
Skin foldsb: 98 (24.7) Skin folds: 29 (14.1) 0.002**
History
of atopic
dermatitisb
109 (36.1) 58 (36.3) 0.998
Missing: 141
Data are presented as n (%).
Medicament (þ) ¼ patients who reacted to at least one positive antigen on patch
testing; Medicament () ¼ patients who had negative results on patch testing.
*p < 0.05.
**p < 0.05.
***p < 0.05.
a Student t test
b Chi-square test
c Two-sided Fisher's exact test.
Figure 1 Main categories of relevant allergens in patients with allergic contact
dermatitis to topical medicaments. NSAID ¼ nonsteroidal anti-inﬂammatory drug.
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at risk include eyes,8 vulvae,9 perianal areas,10 and leg ulcers.11
The objective of this study is to investigate the clinical features
and common allergens of ACD to topical medicaments in Taiwan.
Methods
Patient history and demographics
The patient data in our study was collected in the Contact
Dermatitis Clinic of the National Taiwan University Hospital, a
medical center for patch testing in northern Taiwan. The patients
consisted of Taiwanese, Hakka, aborigines, and immigrants from
Mainland China.12 From 1978 to 2005, a total of 3717 patients were
included. For every patient with suspected ACD seen in this clinic, a
questionnaire, as described elsewhere,13 was completed, which
included a detailed history of occupation, affected sites, appearance
of the skin lesions, and the possible exposure source. Personal or
familial atopy diathesis was considered positive if the patients or
their families had atopic dermatitis, allergic rhinitis, or asthma. This
study followed the Declaration of Helsinki on medical protocol and
ethics. Written informed consent was obtained from all partici-
pating adult patients and from parents or legal guardians for mi-
nors or incapacitated adults.
Patch testing
Every patient with suspected ACD to topical medicaments received
a comprehensive patch test with the European standard series, and
the related topical agents were also patch tested. Patch testing
followed the protocol recommended by the International Contact
Dermatitis Research Group with Finn Chambers (Epitest Ltd Oy,
Tuusula, Finland) on Scanpor tapes (Norgesplaster AS, Vennesla,
Norway) applied to a lesion-free area on the back. The Scanpor
tapes were further afﬁxedwith 3M (3M, St Paul, MN, USA) tape. The
patches were removed after 2 days; the sites were examined for
evidence of reaction on Day 2 (D2) and D4 or on D3 alone. The
reading on D3 or D4 was considered positive if the reaction was
equal to or stronger than palpable erythema, according to the
guidelines of the International Contact Dermatitis Research
Group.12,14
Study design
Patch test data were retrospectively analyzed. Patient history and
demographics disclosed in the questionnaire were compared using
proper statistics. ACD to topical medicaments was deﬁned as hav-
ing a positive reaction to at least one of the topical medicaments in
the patch test series. The clinical relevance of a positive patch test
reaction was deﬁned as previously reported.15
Results
From 1978 to 2005, 3717 patients were patch tested in our Contact
Dermatitis Clinic. Among them, 608were suspected to be allergic to
topical medicaments, of whom 603 completed the patch tests. Of
the 603 patch-tested patients, 397 (66%) were positive for at least
one antigen, and all patch tests were negative in 206 (34%). Patient
history and demographics are summarized in Table 1. Patients who
reacted to at least one positive antigen on patch testing were
deﬁned as “Medicament (þ),” while patients who had negative
results were deﬁned as “Medicament ().” The mean age in the
Medicament (þ) group (36.9 ± 15.9 years) was signiﬁcantly less
than that of the Medicament () group (40.1 ± 17.5 years). More
lesions of the upper limbs, lower limbs, and skin foldswere noted inthe Medicament (þ) group, while more lesions of the face and
trunk were noted in the Medicament () group. No difference in
sex or atopy diathesis was found among the two groups.
A total of 1076 positive reactions to identiﬁable medicaments or
main ingredients were recorded in 397 patients with positive patch
testing. The frequency of positive reactions to topical medicaments
in each patient were as follows: 138 patients had reactions to only
one topical medicament, 90 had ACD to two medicaments, 51 had
reactions to three medicaments, and 118 had reactions to more
than four medicaments.
Among these positive reactions, 701/1076 counts (65%) were
read as relevant. Traditional herbal medicaments (50%), antiseptics
(21%), vehicle ingredients (9%), antibiotics (8%), corticosteroids
(2%), anesthetics (2%), and NSAIDs (1%) were the most common
sensitizers in this study (Figure 1). The top ﬁve common allergens
in traditional herbal medicaments were wind oil, Red Tiger Balm,
White Tiger Balm, nutmeg oil, and eucalyptus oil (Table 2).
Thimerosal, ammoniated mercury, nitrofurazone, mercurochrome,
and betadine were common allergens in antiseptics, while form-
aldehyde, amerchol 101, hydrophilic ointment, cetylstearyl alcohol,
eucerin, and paraben mix ranked high as common allergens in
vehicles (Table 3). Importantly, neomycin sulfate caused much
more positive patch test reactions than fusidic acid, tetracycline,
and chloramphenicol (Table 3). To a total of 53 positive patch test
reactions to antimicrobials, neomycin contributed 32 counts (60%).
By contrast, ﬂuocinonide (Topsym cream), ﬂuticasone (Cutivate
Table 2 Common allergens in traditional herbal medicaments in Taiwan.
Traditional herbal medicaments Counts of
positive reaction
Wind oil 43
Red tiger balm 42
White tiger balm 39
Nutmeg oil 22
Eucalyptus oil 21
White ﬂower oil 15
Chinese herb drug (anonymous) 13
Caryophylli 10
Caulis impatientis 9
Peppermint oil 9
Cortex radix acanthopanacis 8
Cortex cinnamomi 8
Radix angelicae pubescentis 8
Resina draconis/Sanguis draconis 8
Camphor oil 7
Menthol 6
Radix aucklandiae 6
Fructus cnidii 6
Rhizoma ligustici chuanxiong 6
Radix gentiana macrophyllae 6
Green oil 5
Red ﬂower oil 5
Flos carthami tinctorii (safﬂower ﬂower) 5
Pyritum (pyrites) 5
Radix angelicae sinensis (Chinese angelica root) 4
Radix aconiti lateralis praeparata
(prepared common monkshood daughter root)
4
Cornu cervi pantotrichum (hairy antler, pilose antler) 4
Rhizoma acori tatarinowii (grassleaf sweetﬂag rhizome) 3
Rhizoma dioscoreae septemlobae
(sevenlobed yam rhizome)
3
Myrrha (myrrh) 3
Herba lycopodii 2
Rhizoma arisaematis 2
Rhizoma pinelliae (ternate pinellia rhizome) 1
Radix angelicae dahuricae (Dahurian angelica root) 1
Secretio moschus (musk, moschus) 1
Radix cyathulae ofﬁcinalis (medicinal cyathula root) 1
Clove oil 1
Ylang-Ylang oil 1
Y.-H. Shih et al. / Dermatologica Sinica 33 (2015) 181e186 183cream), and oxytetracycline and hydrocortisone (Terra-Cortril)
were among few allergens found in corticosteroids. Other common
allergens in medicaments in Taiwan are also listed in Table 3.
Concomitant allergens were observed in 113 patients. Theywere
classiﬁed into fragrance (52%), metal (20%), rubber (8%), cosmetics
(7%), and other categories (Figure 2). A full list of common
concomitant allergens is provided in Table 4.
Discussion
This hospital-based retrospective study provides demographic and
clinical data for ACD to topical medicaments in Taiwan, which also
emphasizes the special cultural consideration in Asian patients
with ACD to topical medicaments. In our study, 65% of positive
patch test reactions reveal clinically relevant ACD. We suggest that
clinicians should always be alert to the possibility of ACD to topical
medicaments when the treatment response is poor or the treat-
ment course is prolonged.
The effect of age on ACD to topical medicaments is still debat-
able. Some investigators found that elderly people were more
prone to ACD to topical medicaments.5 Conversely, others argued
that people from different age groups are equally likely to have
ACD, although the frequency of relevant allergens may differ.16
Surprisingly, patients with positive patch testing were character-
ized by younger age in our study. One possibility is that elderly
patients with suspected ACD to medicaments are more likely tohave irritant contact dermatitis from impaired barrier function
rather than true allergy to the medicaments. Another possibility is
that the sensitization potential may decrease with age, as has been
shown in a previous study that hypersensitivity to nickel steadily
decreased with age.17
Our study demonstrated that patients with lesions on the limbs
and skin folds had higher positive patch-testing rates. Stasis ulcers
had long been associated with increased hypersensitivity to topical
medicaments. Aggravating factors include prolonged course,
damaged skin barrier of these chronic ulcers, and usage of occlusive
bandages.3 In a large-scale study in France, allergy to lanolin and
neomycin accounts for 21% and 9%, respectively, of patients with
stasis ulcers.11 By comparison, the common sensitizers in patient
with stasis ulcers were topical antibiotics (18.2%) and topical
traditional Chinese medicaments (15.9%) in Singapore.18
Topical medications are also among the most common sensi-
tizers in anogenital dermatoses,9,10 rosacea, and allergic contact
conjunctivitis. However, we found that patients with positive patch
testing were less likely to have facial lesions. In a retrospective
patch-testing study for rosacea patients, only two of 329 patients
were positive to neomycin sulfate and one of 100 patients were
positive to gentamicin sulfate.19 Thus, irritant reaction may play a
more important role than allergic reaction in rosacea patients.
Common allergens in ophthalmic solutions include preservatives,
beta blockers, mydriatics, antibiotics, antiviral drugs, antihista-
minics, anesthetics, and enzymatic cleaners.20 In our study, we
reviewed seven cases who had ACD to eye drops. Interestingly, six
of them showed allergy to antibiotics, such as neomycin or
fradiomycin.
As noted in earlier reports, atopic patients are more difﬁcult to
be experimentally sensitized to nonprotein allergens and may
therefore be less likely to develop ACD.21 Nevertheless, topical
medicaments had been demonstrated as allergens in children with
atopic dermatitis.22 Our study revealed that atopic patients would
develop ACD at least as often as nonatopic individuals, which was
consistent with previous studies.23,24
Traditional herbal medicaments were the most common topical
agents that cause ACD in our study. In Asian communities, tradi-
tional herbal medicaments are largely sold as over-the-counter
products and can be accessed very easily. Usually, these tradi-
tional herbal medicaments contain terpenes, salicylates, essential
oil extracts, and other crude herbal drugs.25,26 Colophony,
fragrance, and myrrh are rather frequent allergens in these prep-
arations, and cross-sensitization with these plant extracts con-
tained in traditional herbal medicaments is often.3 In our previous
study, 11.4% of patients who reacted to fragrance mix also had
concomitant reactions to topical medicaments.27
Red Tiger Balm, White Tiger Balm, and White Flower Oil were
among the top 10 allergenic traditional herbal medicaments in our
study. Previously, similar ﬁndings had also been observed in
Singapore28 and Germany.29 These topical drugs are usually not
well labeled. The typical use information provided to the patients
discloses only “essential oils” and “aroma agents.”29 Ingredients of
the Tiger Balms include camphor, menthol, cajuput oil, clove oil,
dementholized mint oil, and parafﬁn petrolatum.30 Menthol is a
cyclic terpene alcohol, a main component of peppermint oil, and is
widely used in medicaments, cosmetics, and confectionaries as a
cooling agent. Allergic sensitization tomenthol is rare.31 Yet several
reports indicated that menthol sensitizationwas possible through a
compress or transcutaneous patch.31,32 These application methods
are widely used in Asian communities to enhance the penetration
of the ingredients.
Compresses containing methyl salicylate or NSAIDs are also
commonly used for muscular pain in Asian communities, but they
can cause allergic and photoallergic contact dermatitis.33 Again,
Table 3 Other common allergens in medicaments in Taiwan.
Counts of
positive reaction
Antiseptics
Thimerosal 39
Ammoniated mercury 35
Nitrofurazone 18
Mercurochrome 16
Betadine 15
Quinoline mix 10
Mercury bichloride 5
Clioquinol 4
Resorcin 2
Over-the-counter compound formulas with antiseptics 2
Chlorquinaldol 1
Azohel (chrysoidine hydrochloride citrate) 1
Phenylmercuric acetate 1
Vehicle ingredients/preservatives/antioxidants
Formaldehyde 19
Amerchol 101 8
Hydrophilic ointment 7
Cetylstearyl alcohol 7
Eucerin 6
Paraben mix 5
Polyethyl glycol 400 (polyethylene glycol 400) 3
Wool alcohols 3
Carbowax 2
Propylene glycol 2
Ethylene diamine (ethylenediamine dihydrochloride) 1
Polyethyl glycol 6000 1
2-n-Octyl-4-isothiazolin-3-one 1
Antimicrobials
Neomycin sulfate 32
Fusidic acid 5
Tetracycline 5
Over-the-counter compound formulas with antibiotics
(neomycin sulfate, diphenylpyraline hydrochloride,
nylidrin hydrochloride, hydrocortisone; neomycin
sulfate, bacitracin, polymyxin B sulfate; bacitracin,
neomycin)
3
Chloramphenicol 3
Silver sulfadiazine 2
Bacitracin 1
Gentamicin 1
Acyclovir (Zovirax) 1
Corticosteroids
Fluocinonide (Topsym cream) 5
Fluticasone (Cutivate cream) 2
Oxytetracycline and hydrocortisone (Terra-Cortril) 2
Over-the-counter compound formulas with unlabeled
corticosteroid
2
Betamethasone valerate (Rinderon-V cream 0.06%) 1
Betamethasone dipropionate (Septon cream 0.064%) 1
Fluclorolone acetonide (Topicon) 1
Tixocottol-21-pivalate 0.1 pet 1
Hydrocortisone (Cort. S) 1
Clobetasol-17-propionate (Bestasol) 1
Anesthetics
Benzocaine 11
Procaine 3
Ethylamine benzoate 1
Para-aminobenzoic acid 1
Pramoxine 1
NSAIDs
Over-the-counter compound formulas with salicylates 4
Phenyl salicylate 1
Methyl salicylate 1
Ketoprofen (Formax) 1
Etofenamate 1
Indomethacin 1
Eye drops
Compound formulas containing combinations of
dexamethasone phosphate, neomycin sulfate,
or amphomycin calcium
5
Betamethasone disodium phosphate, fradiomycin
sulfate (Eye Rinderon-A ointment)
1
Fluorometholone (Flumetholon eye drop) 1
Table 3 (continued )
Counts of
positive reaction
Miscellaneous
Benzoyl peroxide 11
Pyrogallol 11
Hydroquinone 7
Sulfur 5
Chemical peeling agents containing phenol,
resorcinol, or salicylic acid
3
Sulfanilamide 1
Potassium iodide 1
Urea 1
Monobenzone 1
NSAID ¼ nonsteroidal anti-inﬂammatory drug.
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Red Flower Oil and White Flower Oil, contain methyl salicylate.34
Like other salicylates, methyl salicylate may cause fetal salicylate
intoxication in children through percutaneous absorption. Local-
ized or generalized urticaria had been reported as well. ACD or
irritant contact dermatitis is common, especially under occlu-
sion.35,36 As for other NSAIDs, ketoprofen is famous for causing
allergy and photoallergy. Noticeably, most cases of ketoprofen
sensitization reported to date were from the Mediterranean area,
including a large series in France reviewing 136 patients.37 Never-
theless, in our 20 years of experience, we found only one patient
who had photoallergy to ketoprofen, possibly due to the different
ethnic/genetic background, skin phototypes, or regional prescrip-
tion habits. Another NSAID, etofenamate, is a highly lipophilic an-
thranilic acid derivative. Only a few ACD and photo-ACD cases, and
one case of contact urticaria to etofenamate had been reported.38
Neomycin accounted for 60% of positive reactions to antibiotics,
which corresponded to 5.3% of all the patients patch tested in our
study. According to the North American Contact Dermatitis Group,
the sensitization rates of neomycin stayed relatively constant be-
tween 10% and 13% from 1994 to 2006. Thus, it was named the
allergen of the year in 2010.39 A study from United Kingdom
showed that the frequency of medicament allergy to neomycinwas
10 times more common than that to fusidic acid.40 The ratio was
less striking in our study, reﬂecting that neomycin sensitization in
Taiwan may be underestimated.
Documented ACD from acyclovir was rare, and many suggested
that the skin reactions were being attributed only to the vehicle
components, such as sodium lauryl sulfate and propylene glycol.41
We found that in one patient patch tests were positive to acyclovir
cream, but the patient was not further patch tested with the vehicle
tray.Figure 2 Main categories of concomitant allergens in patients with allergic contact
dermatitis to topical medicaments.
Table 4 Common concomitant nonrelevant allergens in patients with contact
dermatitis to topical medicaments.
Counts of positive
reaction
Fragrance
Fragrance mix 53
Balsam of Peru 46
Colophony 33
Cinnamyl alcohol 16
Eugenol 15
Isoeugenol 8
Cinnamaldehyde 7
Star cologne 6
Perfume 5
Oak moss absolute 4
Alpha-amyl-cinnamaldehyde 2
Turpentine 2
Geraniol 1
Metal
Nickel sulfate 54
Cobalt chloride 22
Copper sulfate 1
Rubber
Paraphenylenediamine dihydrochloride 12
Carba mix 6
Thiuram mix 5
Tetramethylthiuram monosulﬁde 2
Mercapto mix 1
Mercaptobenzothiazole 1
Rubber 1
Tetramethyl thiuram 1
Tetramethylthiuram disulﬁde 1
Tetraethylthiuram disulﬁde 1
Cosmetics
Personal care products 14
Colored (make-up) cosmetics 5
Sodium lauryl sulfate, hair preparation,
lauryl sulfate
5
Sun screen 1
Adhesives/dye
Paratertiary butylphenol formaldehyde
resin
11
Potassium dichromate 4
Epoxy resins 2
Shoe 1
Vehicles
Propolis 6
Hair dye
3-Aminophenol 1
4-Aminophenol 1
p-Toluenediamine sulfate 1
Miscellaneous 13
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solutions, and other eye preparations, ranked high among the
common antiseptic sensitizers in our study, and so does mercuro-
chrome, another widely used mercurial for surgical disinfection
and wound care in the past in Portugal, Spain, and Taiwan.42 It was
very difﬁcult to establish the relevance because mercurials were
ubiquitous in vaccines or ophthalmic products, and cross-reactions
between mercurials were frequent. By contrast, one study showed
that persons allergic to thimerosal were more likely to be allergic to
neomycin, bacitracin, and tixocortol pivalate,43 suggesting a close
relationship between thimerosal and topical medicaments.
Nitrofurazone, quinolines, and betadine were also identiﬁed as
allergenic antiseptics in this study. Nitrofurazone and quinolines
are well-known sensitizers. Contact allergy to clioquinol occurred
more often than that to chlorquinaldol. Nevertheless, cross-
reaction existed.44 Providone-iodine could induce skin irritation,
necrosis, and rarely contact allergy.45
We found that topical corticosteroids and local anesthetics
accounted for only 2% of positive reactions, respectively, in patientswith suspected ACD to medicaments. Topsym cream is the most
common allergenic topical corticosteroid in our study. The culprit
allergen in Topsym creammight be 1,2,6-hexanetriol present in the
cream base.46 Alternatively, we noticed one in ﬁve patients to be
allergic to Topsym cream who also had concomitant reaction to
formaldehyde. Some believed that formaldehyde and formalde-
hyde releasers accounted for themajority of reactions in the vehicle
and preservative groups in topical corticosteroids.47
Formaldehyde-releasing preservatives are well-known aller-
gens in topical preparations including medicaments.48 Formalde-
hyde sensitization was noted in 3.1% of patients in our study, while
propylene glycol, another common allergenic component in vehi-
cles, played no role. The overall prevalence rate of formaldehyde
sensitivity was 3.8% in Taiwan,49 which was slightly higher than the
rate (1.3%) published recently by a network in Germany,
Switzerland, and Austria.50 Our government banned formaldehyde
use in cosmetics only after 2005, and there is still no regulation on
its use in medicaments.
Benzocaine is the most common allergen in topical anesthetic
agents, and is often used to treat pruritus ani, hemorrhoids, or
pruritus vulvae. Many studies suggested that cross-reactions of
benzocaine with other ester derivatives, such as cinchocaine,51 and
amide derivatives, such as lidocaine,52 occurred frequently. Thus,
they concluded that patch testingwith benzocaine single agent was
inappropriate. However, we did not observe this phenomenon. In
terms of topical antihistamines, diphenhydramine, chlorphenir-
amine, promethazine, chlorpromazine, and doxepin are famous
sensitizers.3 None of the above was noted in this series.
As we mentioned above, concomitant allergies to fragrance and
traditional herbal medicaments were widely reported and well
demonstrated in our study. Besides fragrance, we discovered that
9.0% of the patients patch tested for suspected ACD tomedicaments
were also sensitive to nickel and 3.6% to cobalt. The overall prev-
alence rates of nickel and cobalt sensitivity were, respectively, 17.7%
and 7.1% in Taiwan.13 The above results indicate that there was no
obvious cross-sensitization among medicaments and these two
common metal allergens.
The limitations of our study include the following: it was a
retrospective study; patients were selected in a specialized clinic;
irritancy reaction may cause false-positive results; low concentra-
tion in the whole complex product may cause false-negative
results; only selective patients were patch tested with vehicle tray;
not all the manufacturers had a goodwill for ingredient labeling;
and for some ingredients, correct concentration and vehicle for
patch tests were not determined.References
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